To use sheep and rat models and demonstrate that stressors activate fetal glucocorticoid (GC) system, corticotrophin-releasing factor (CRF) system and cholinergic neurotransmitter system (ChNS) leading to propulsive colonic motility and in utero meconium passage. Immunohistochemical studies (IHS) were performed to localize GC-Receptors, CRF-receptors and key molecules of ChNS in sheep fetal distal colon. CRF expression in placenta and enteric endocrine cells in fetal rat system were examined and the effects of acute hypoxia on in utero meconium passage was tested. IHS confirmed localization and gestation dependent changes in GC-Rs, CRF-Rs and cholinergic markers in sheep fetal colon. Rat placenta and enteric endocrine cells express CRF and gastrointestinal tract express CRF-Rs. Hypoxia is a potent inducer of meconium passage in term fetal rats. Stress is a risk factor for in utero meconium passage and laboratory animal models can be used to develop pharmacotherapy to prevent stress-induced in utero meconium passage.
Introduction
Newborn meconium passage, a developmentally programmed event, normally occurs within the first 24-48 h after birth, although little is known of the regulatory process. Clinically, a delay in newborn meconium passage has been observed in infants born with Hirschprung disease, a defect involving the absence of intrinsic ganglia in colon. 1 In contrast, we have no similar anatomical or neurochemical explanations for the meconium staining observed in 7-22% of all term deliveries. 2 Greater than 90% of cases of clinically observed meconium-stained amniotic fluid are noted in fetuses at or following 37 weeks gestation, being uncommon in preterm deliveries. 3 Passage of meconium occurs most often in deliveries beyond 40 weeks of gestation. 4 An increased incidence of meconium passage in amniotic fluid is noted in the presence of fetomaternal stress factors such as hypoxia and infection, independent of fetal maturation. 5, 6 On the basis of the clinical observations, fetal stress and gastrointestinal maturation have been attributed as risk factors responsible for meconium passage as well as the potential meconium aspiration in utero. Despite these risk factors, presently very little is known of the cascade of events that leads to meconium passage in the newborn immediately after birth or to the mechanisms contributing 'premature' meconium passage in utero. There are no small or large animal models that could be extrapolated to humans. We review here recent studies gathered in our laboratory in rat and sheep models directed toward understanding the cellular and molecular basis of stress-induced in utero meconium passage.
Stress and gut motility: lessons learned from laboratory animals Although impact of emotional stress on gastric and colonic motor activity has long been known in humans only during the past two decades, much attention has been paid to understand the neural circuitry and hormonal effectors that mediate effects of stress on gut functions in animal models (see review 7, 8 ). The rat is a widely used animal model for stress-related alteration on gut motor functions, although limited investigation has also been performed in mouse models. 9 Inhibition of gastric emptying, gastric secretion, gastric contraction and stimulation of colonic motility and defecation have now been well established in adult rats as the hallmarks of neurovisceral motor responses to stressors of psychological, physical, chemical and immunological origin. [10] [11] [12] [13] Members of stress hormone family, more specifically corticotrophin-releasing factor (CRF) and urocortin, have been shown to mimic multifaceted acute responses to stress. 8 Both hormones mediate their actions through CRF-receptor subtype 1 (CRF-R1) and CRF-receptor subtype 2 (CRF-R2). Both receptors are encoded by distinct genes and both are G protein-coupled receptors linked to multiple intracellular signaling pathways. 14 Of the two CRF receptor subtypes, CRF-R1 stimulates colonic motility and defecation, whereas CRF-R2 inhibits gastric emptying and gastric contraction at times of stress. 15 Anatomical, physiological, pharmacological and biochemical studies have provided unambiguous evidence that the CRF system (CRF, urocortins, CRF-R1 and CRF-R2) is the key player of gastrointestinal motility disturbance during times of stress. 7, 16 Hypothesis: in utero meconium passage is a fetal neurovisceral motor response to stress We hypothesize that in utero meconium passage is a neurovisceral motor response to fetal stress and that the CRF system plays a critical role in the stimulation of cholinergically mediated fetal colonic propulsive motor functions that trigger meconium passage. An integrated model proposed for fetal in utero meconium passage is shown in Figure 1 . The salient points of our hypothesis are as follows: fetal-maternal stress leads to increased fetal plasma glucocorticoids, which stimulate the synthesis of placental CRF. 17 Stress-induced increase in glucocorticoids are also speculated to upregulate the CRF-R1 density 18 on the myenteric neurons as well as the expression of peripheral choline acetyltransferase, 19 the enzyme that catalyzes the synthesis of acetylcholine, the principle neurotransmitter that regulates the motor activity of gastrointestinal system. In conditions of stress, increased maternal and/or fetal sympathetic tone will lead to increased circulating levels of catecholamines, which are known stimulators of placental CRF release. 20 Thus, stress-induced activation of the CRF-CRF-R1 system at the level of myenteric neurons will evoke release of acetylcholine, increased colonic smooth muscle motility and in utero meconium passage.
Stress is a potent stimulator of in utero meconium passage in term fetal rats Although clinical signs of stress due to hypoxia are frequently observed in human neonates born with meconium staining, there is no direct evidence to support the fact that hypoxic stress is a risk factor for in utero meconium passage. We recently developed a novel hypoxic stress paradigm to demonstrate that hypoxic stress at term will provoke in utero meconium passage. 21 The experimental design includes exposure of term pregnant rats (term ¼ 22 days) at 22 days of gestation to decreasing concentration of oxygen in a stepwise manner as illustrated in Figure 2a . Fetuses removed from uterine horn at the end of hypoxic exposure were alive and exhibited thick meconium staining as shown in Figure 2b , whereas control fetuses did not exhibit meconium.
Examination of fetal and maternal plasma revealed a marked elevation in CRF levels, 21 suggesting that the peripheral CRF pathway may mediate the stimulation of fetal colonic motility and meconium passage. As acute hypoxia-induced meconium passage has a rapid onset, the mechanisms underlying the peripheral pathway most likely involve the activation (directly and neurally) of fetal adrenal epinephrine and norepinephrine secretion as well as sympathetic nervous system norepinephrine release, which in turn stimulate placental CRF exoctyosis. Recent studies in our laboratory indicate that rat placenta, similar to human placenta, is a site of CRF synthesis. 22, 23 In addition, enteric endocrine cells expressing CRF in term rat fetal gut could also function as a potential local source, as speculated in humans. 24, 25 Increased peripheral CRF in the fetus stimulates colonic motility through myenteric CRF-R1 and rapid meconium passage ( Figure 3a) . The central CRF pathway involves activation of CRF neurons in paraventricular brain nuclei directly innervating colonic segments, as has been demonstrated in adult rats (Figure 3b) . Thus, acute hypoxic stress-induced in utero meconium passage involves release of stored CRF protein pool from peripheral and/or central tissues. Ongoing studies in our laboratory also support the expression of CRF-R1 in smooth muscle and enteric neuronal circuitry in term rat fetal gastrointestinal tract, 26 lending strong anatomical support for our hypothesis that intrauterine stress may impact gut motility through CRF-R1 in a manner analogous to stress-induced stimulation of colonic motility and defecation in adult rats. 15 Lessons learned from sheep model in support of stress-induced in utero meconium passage Sheep are used in our laboratory as a large animal model for understanding the molecular mechanism of in utero meconium passage. [27] [28] [29] The larger size of the gut and longer gestational age permit in vivo studies exploring gestation-and hormone-dependent changes in gastrointestinal motility, and in vitro organ bath studies examining smooth muscle contractility. The large fetal size permits withdrawal of blood in sufficient quantities for evaluating circulating hormone and cytokine levels. In the following section, we summarize some of our investigations relevant to hormonal regulation of sheep fetal distal colonic motility as well as recent progress made on the ontogeny of glucocorticoid receptor system, CRF system and cholinergic synaptic circuitry system in fetal distal colonic segments. In addition, we discuss our recent advances in support of knowledge of CRF signaling system in the prevention of in utero meconium passage before term.
Sheep fetal colon is a glucocorticoid target organ As the incidence of meconium-stained amniotic fluid increases with increase in gestational ages and fetal stress, we hypothesized that fetal colon could be a glucocorticoid target organ with fetal colonic motility function regulated by glucocorticoids. 27 We examined in vivo effects of betamethasone (a synthetic glucocorticoid) in the presence and absence of thyroxine on in vitro colonic smooth muscle cholinergic contractility. 27 Muscle strips prepared from sheep fetuses that received intramuscular injection of betamethasone alone or in combination with thyroxine exhibited greater contractile responsiveness to bethanechol (a cholinergic agonist) than muscle strips prepared from vehicle-treated fetuses. These glucocorticoid-specific changes were noticed 48 h after intramuscular injections of betamethasone, suggesting that glucocorticoids regulate cholinergic contractile maturation through 'genomic' actions. The findings obtained following glucocorticoid administration has provided partial support for our hypothesis that stress-mediated glucocorticoid release may stimulate colonic motility and meconium passage.
We also examined the in vivo effect of bethanechol on colonic muscular contractile and electromyogram activity in the sheep fetus. 28 We noticed increased strain gauze activity in response to bethanechol infusion in transverse but not in distal colon at 0.9 gestation (135 days gestation, term ¼ 150 days). This finding suggested the presence of a local inhibitor system for cholinergic-dependent contractility in the distal colon before term, perhaps serving as an intrinsic mechanism to prevent premature meconium passage.
Localization and gestation-dependent changes in glucocorticoid receptor expression in sheep fetal distal colon To validate our hypothesis that sheep fetal colon is glucocorticoid target organ, we undertook studies to evaluate the cellular localization and gestation-dependent changes in glucocorticoid receptors in sheep fetuses at very preterm (118-120 days), preterm (130-132 days), near term (140-142 days) and term (146-147 days) gestation. 30 Glucocorticoid receptor antibody elicited positive staining in smooth muscle layers as well as in myenteric and submucosal neurons at all stages of development with maximal expression noticed at near term, suggesting the profound changes in nuclear transcription machineries begin to occur at near term. We also noticed a robust change in fetal plasma cortisol levels at term, suggesting that the expression of glucocorticoid receptors could be turned 'off' by glucocorticoids at term, or immediately after birth, as circulating levels of glucocorticoids reach basal levels within 24 h after birth in many species including humans.
Evidence for prereceptor metabolism of glucocorticoids in fetal sheep distal colon Glucocorticoid actions at the cellular level are controlled by 11-beta hydroxysteroid hydrogenase (11bHSD) type 1 and type 2, enzymes that regulate the interconversion of active glucocorticoid and their inactive 11-keto metabolites. We recently examined the presence of 11 bHSD-1 and 11 bHSD-2 in sheep fetal colonic enteric nervous system as evidence that these enzymes provide a novel means for regulation of glucocorticoid-mediated 'genomic' activities. 31 The antibodies to 11bHSD-1 and 11 bHSD-2 elicited positive immunostaining of both myenteric and submucosal ganglia at all gestation ages. The percentage of myenteric ganglia expressing 11bHSD-1 and 11bHSD-2 were maximal at term. The percentage of submucosal ganglia expressing 11bHSD-1 was maximal at term, whereas the expression of 11bHSD-2 remained constant throughout gestation. We speculate that increasing levels of 11bHSD-1, and thus increased active glucocorticoid levels, at term could contribute to glucocorticoid-dependent colonic contractile maturation.
CRF system
Identification and gestation-dependent changes in CRF system in sheep fetal distal colon We recently undertook a systematic investigation to obtain anatomical support that CRF system is an integral component of distal colonic contractility apparatus. 32 Our findings can be summarized as follows: CRF-R1-and CRF-R2-specific antibodies strongly immunostained longitudinal and circular smooth muscles in addition to muscularis mucosa in colonic segments at all gestational ages. A marked decrease in CRF-R2 immunostaining occurred in smooth muscle layers close to term. CRF-R1 antibody immunostained neuronal somas both in myenteric and submucosal ganglia, and the percentage of ganglia expressing CRF-R1 were maximal at term gestation. On the basis of the reciprocal changes in CRF-R1 and CRF-R2 expression in the smooth muscle-enteric unit, we speculate that CRF-R1 could be hyper-responsive to stressors that stimulate the release of endogenous CRF leading to increased motor activity and meconium passage.
Cellular localization of CRF-binding protein in sheep distal colon
Corticotrophin-releasing factor-binding protein is a protein known to compete with CRF-R1 and CRF-R2 for CRF and urocortin. 33 Our immunohistochemical investigation revealed expression of CRF-binding protein in the smooth muscle-enteric unit. 34 We observed a marked decrease in smooth muscle expression of CRF-binding protein and a simultaneous increase in myenteric neuronal somas at term, indicating that this protein is a critical regulator of CRF and urocortin functions at the level of smooth muscle-enteric unit in sheep fetal distal colon.
CRF signaling system may play a role in preventing in utero meconium passage before term We performed in vitro study of sheep fetal colonic contractility to assess the significance of CRF receptor system. 29 In these studies, colonic smooth muscle strips prepared from preterm sheep fetal distal colonic segments were subjected to cholinergically dependent contractility in an organ bath system following pre-incubation with CRF or urocortin. Both neuropeptides significantly decreased the cholinergically stimulated contractility. Immunohistochemical studies confirmed the expression of muscarinic receptor subtype 3 and CRF-R2 in preterm sheep fetal colon. Additional studies revealed positive immunostaining for CRF and urocortin in smooth muscle and enteric neurons, indicating the local availability of neuropeptides to inhibit smooth muscle motility during the time of stress. 29 All in all, stress hormones (CRF and urocortin) and stress hormone receptors (CRF-R1 and CRF-R2) appear to function in parallel or series pathways, and CRF-R2 plays a central role in preventing stress-induced in utero meconium passage before term.
Cholinergic circuitry system
Maturational changes in sheep fetal colonic cholinergic circuitry system parallels plasma glucocorticoid surge We utilized antibodies specific to vesicular acetylcholine transporter, a high-affinity choline transporter, and peripheral choline acetyl transferase as markers for cholinergic synaptic circuitry system to examine the maturation of cholinergic system in distal colon of sheep fetuses from very preterm to term gestation. 35 The percentage of myenteric ganglia expressing cholinergic markers in term fetuses were significantly higher than those observed in preterm. The marked increase observed in cholinergic markers in myenteric ganglia in fetal distal colon at term is possibly mediated by effects of endogenous glucocorticoid levels, which peak at term. We speculate that glucocorticoid is the physiological hormone that regulates enteric cholinergic neural synaptic circuitry system similar to their actions in central nervous system regions.
Localization of inhibitory and stimulatory muscarinic receptor subtypes in sheep fetal distal colon: implication for meconium passage Acetylcholine mediates gastrointestinal motility through muscarinic receptors. To date, five muscarinic receptors (M1-M5) have been cloned, with M3 confirmed as the prominent mediator of smooth muscle contraction. Of the other subtypes, M1, M2 and M4 have been shown to function as potent autoinhibitor (that is, inhibitory presynaptic muscarinic receptor) of Ach release from myenteric plexus. We examined the maturation and topographical distribution of muscarinic receptor subtypes in distal colon from very preterm to term.
36 M1-M5 antibodies elicited positive staining in colonic sections at all gestational ages. M4 is expressed most abundantly in circular and longitudinal smooth muscle layers, whereas M3 is expressed in rather low levels. Positive immunostaining for both M5 and M1 in smooth muscle layers are similar, but their immunostaining intensity was significantly lower compared with M3, M4 and M2. The percentage of neurons expressing inhibitory autoreceptors (M1, M2 and M4) in the enteric ganglia was markedly higher in distal colonic sections of preterm and near-term fetuses, with expression declining rapidly and markedly at term. Our results indicate that before term, muscarinic autoreceptors may inhibit presynaptic release of Ach and consequently limit the cholinergically mediated smooth muscle contractility. This could represent a physiological mechanism analogous to CRF-R2 functions in preventing stress-induced in utero meconium passage before term. The rapid decline of muscarinic inhibitory autoreceptors noticed at term most likely relieves the colonic contractile machinery from auto-inhibition and will increase efficacy of cholinergic synaptic transmission, facilitating ready responsiveness of colonic contractile machinery to Ach.
In summary, we have established for the first time a rat model for stress-induced in utero meconium passage. We have further obtained anatomical support for the expression of key molecules of glucocorticoid system, CRF system and cholinergic circuitry system in sheep fetal distal colon. All three systems seem positioned in distal colon readily to respond to stress. Our studies unexpectedly revealed the presence of potential mechanisms to prevent the in utero meconium passage before term, including the expression of CRF-R2. Future studies should improve our understanding of the mechanisms of in utero meconium passage and possibly to develop pharmacotherapy to prevent stress-induced in utero meconium passage and consequences of meconium aspiration.
